glp 1 agonist injection Generic Liraglutide (Victoza) Becomes First Generic GLP-1 Receptor Diabetes Patients Also Struggle to

Description

Food and Drug Administration (FDA) to treat type 2 diabetes and obesity

Diabetes Care 36 , 24892496 (2013)

Liraglutide and N-AcGIP established an important glycemic control, but the association of Liraglutide plus N-AcGIPdid not present a significant effect when compared to Liraglutide or N-AcGIP administered alone

Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide

As mentioned above, a GLP-1 receptor agonist works by mimicking the natural incretin hormone (hormones secreted by the gut) GLP-1, which may assist in lowering blood sugar in the following ways 7 , 8 : Increase insulin when blood glucose (sugar) is high: They enhance the bodys ability to release insulin when blood sugar levels are elevated